Alongside the public sector, Netrika Medicine continues to actively develop cooperation with the commercial segment of the healthcare market. Company specialists develop solutions and services relevant for private medical organizations and expand expertise in advanced artificial intelligence technologies. Andrey Gul, Chief Technology Officer of Netrika Medicine, summarizes the results.
In 2025, when selecting directions for technological development, Netrika Medicine relied on several key market trends.
In 2025, when selecting directions for technological development, Netrika Medicine relied on several key market trends.
Growing Adoption of AI-Based Solutions
Within the N3.Healthcare integration platform, we consistently develop artificial intelligence technologies. For us, this is not an experiment but a practical tool that already helps solve everyday tasks of medical organizations.
Last year we launched the N3.AI platform, which combined artificial intelligence tools for medical care and analytics in a unified environment. A key element of the platform is AI assistants within the BI module “N3.Analytics”. They automate the creation of reports and dashboards, reducing the time required for these tasks from several hours to just a few minutes.
However, our approach is based not on the number of use cases but on their practical value. Therefore, we currently focus on three priority areas:
In 2026 we will continue developing AI solutions both as components of the N3.Healthcare platform and as standalone services.
One of the key tasks for the near future is a module for assessing the quality of electronic medical record completion within the Integrated Electronic Medical Record (N3.IEMR). We have carried out extensive work to create an MVP and consider this solution not only as a tool for data quality control but also as a way to reduce the workload of medical staff and improve process management.
Among our medium-term plans is the application of AI in telemedicine services and the development of clinical decision support systems (CDSS). In this work we maintain a balance between functionality and reliability: such solutions must not only be useful but also clinically validated.
Our goal is for technologies to take over routine tasks so that specialists can focus on what matters most — helping patients.
Within the N3.Healthcare integration platform, we consistently develop artificial intelligence technologies. For us, this is not an experiment but a practical tool that already helps solve everyday tasks of medical organizations.
Last year we launched the N3.AI platform, which combined artificial intelligence tools for medical care and analytics in a unified environment. A key element of the platform is AI assistants within the BI module “N3.Analytics”. They automate the creation of reports and dashboards, reducing the time required for these tasks from several hours to just a few minutes.
However, our approach is based not on the number of use cases but on their practical value. Therefore, we currently focus on three priority areas:
- automation of routine data operations (implemented through AI assistants);
- intelligent monitoring of the completeness and accuracy of records;
- access to electronic medical services through the national messenger MAX.
In 2026 we will continue developing AI solutions both as components of the N3.Healthcare platform and as standalone services.
One of the key tasks for the near future is a module for assessing the quality of electronic medical record completion within the Integrated Electronic Medical Record (N3.IEMR). We have carried out extensive work to create an MVP and consider this solution not only as a tool for data quality control but also as a way to reduce the workload of medical staff and improve process management.
Among our medium-term plans is the application of AI in telemedicine services and the development of clinical decision support systems (CDSS). In this work we maintain a balance between functionality and reliability: such solutions must not only be useful but also clinically validated.
Our goal is for technologies to take over routine tasks so that specialists can focus on what matters most — helping patients.
Digitalization of the Commercial Healthcare Segment
Commercial medical organizations (clinics, pharmacies, and others) are increasingly implementing digital solutions and expanding data exchange with the public healthcare sector.
Together with the company ElNetMed, we began this work in 2024. In 2025 it expanded significantly and produced substantial results. In particular, a solution for exchanging medical documents between commercial and public clinics has been created and is being actively implemented.
Today we carefully evaluate opportunities for entering international markets with solutions for commercial organizations — including medical, pharmaceutical, and insurance companies.
The export potential of our products is not limited to CIS countries. We see interest from partners in Africa, Asia, and Latin America.
Another promising direction in the Russian B2B segment is the development of a workforce health management platform. It is especially relevant for large companies, particularly industrial enterprises where employees work in conditions that may negatively affect their health.
Commercial medical organizations (clinics, pharmacies, and others) are increasingly implementing digital solutions and expanding data exchange with the public healthcare sector.
Together with the company ElNetMed, we began this work in 2024. In 2025 it expanded significantly and produced substantial results. In particular, a solution for exchanging medical documents between commercial and public clinics has been created and is being actively implemented.
Today we carefully evaluate opportunities for entering international markets with solutions for commercial organizations — including medical, pharmaceutical, and insurance companies.
The export potential of our products is not limited to CIS countries. We see interest from partners in Africa, Asia, and Latin America.
Another promising direction in the Russian B2B segment is the development of a workforce health management platform. It is especially relevant for large companies, particularly industrial enterprises where employees work in conditions that may negatively affect their health.
National Messenger MAX
The MAX messenger is integrated into all government digital services, including healthcare services.
In 2025 we launched a chatbot in MAX that helps citizens schedule doctor appointments, receive telemedicine consultations, and sign informed consent forms digitally with a single click.
In the second half of the year, the first regional projects to implement this solution for our customers were launched.
In 2026 we will continue implementing these projects in the regions where the company operates and will monitor emerging customer needs related to the functionality of the messenger.
The MAX messenger is integrated into all government digital services, including healthcare services.
In 2025 we launched a chatbot in MAX that helps citizens schedule doctor appointments, receive telemedicine consultations, and sign informed consent forms digitally with a single click.
In the second half of the year, the first regional projects to implement this solution for our customers were launched.
In 2026 we will continue implementing these projects in the regions where the company operates and will monitor emerging customer needs related to the functionality of the messenger.